INS and coronary artery disorder: Administration of selenium, at an average dose of 200 μg/d for 3 months, was shown to improve insulin sensitivity and reduce cardiometabolic risk in patients with diabetes with or without congestive heart failure and coronary heart disease [30,31,48].